166 related articles for article (PubMed ID: 33053339)
1. PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer.
Lin LL; Kost ER; Lin CL; Valente P; Wang CM; Kolonin MG; Daquinag AC; Tan X; Lucio N; Hung CN; Wang CP; Kirma NB; Huang TH
Cell Rep; 2020 Oct; 33(2):108253. PubMed ID: 33053339
[TBL] [Abstract][Full Text] [Related]
2. Adipokines Deregulate Cellular Communication via Epigenetic Repression of
Polusani SR; Huang YW; Huang G; Chen CW; Wang CM; Lin LL; Osmulski P; Lucio ND; Liu L; Hsu YT; Zhou Y; Lin CL; Aguilera-Barrantes I; Valente PT; Kost ER; Chen CL; Shim EY; Lee SE; Ruan J; Gaczynska ME; Yan P; Goodfellow PJ; Mutch DG; Jin VX; Nicholson BJ; Huang TH; Kirma NB
Cancer Res; 2019 Jan; 79(1):196-208. PubMed ID: 30389702
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
Chung CL; Sheu JR; Chen WL; Chou YC; Hsiao CJ; Hsiao SH; Hsu MJ; Cheng YW; Hsiao G
Am J Respir Cell Mol Biol; 2012 Apr; 46(4):437-45. PubMed ID: 22033265
[TBL] [Abstract][Full Text] [Related]
4. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.
Byon CH; Hardy RW; Ren C; Ponnazhagan S; Welch DR; McDonald JM; Chen Y
Lab Invest; 2009 Nov; 89(11):1221-8. PubMed ID: 19752858
[TBL] [Abstract][Full Text] [Related]
5. The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.
Gettins PG; Dolmer K
J Biol Chem; 2016 Jan; 291(2):800-12. PubMed ID: 26555266
[TBL] [Abstract][Full Text] [Related]
6. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
7. Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.
Roy A; Coum A; Marinescu VD; Põlajeva J; Smits A; Nelander S; Uhrbom L; Westermark B; Forsberg-Nilsson K; Pontén F; Tchougounova E
Oncotarget; 2015 Sep; 6(27):23647-61. PubMed ID: 26164207
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells.
Sandberg T; Eriksson P; Gustavsson B; Casslén B
Mol Hum Reprod; 1997 Sep; 3(9):781-7. PubMed ID: 9358004
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
Samad F; Yamamoto K; Pandey M; Loskutoff DJ
Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
[TBL] [Abstract][Full Text] [Related]
10. Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF.
Chen C; Sun MZ; Liu S; Yeh D; Yu L; Song Y; Gong L; Hao L; Hu J; Shao S
BMB Rep; 2010 Aug; 43(8):554-60. PubMed ID: 20797318
[TBL] [Abstract][Full Text] [Related]
11. Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.
Berg DT; Myers LJ; Richardson MA; Sandusky G; Grinnell BW
J Biol Chem; 2005 Apr; 280(15):14943-7. PubMed ID: 15716278
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi MC; Bastelica D; Morange P; Berthet B; Leduc I; Verdier M; Geel O; Juhan-Vague I
Diabetes; 2000 Aug; 49(8):1374-80. PubMed ID: 10923640
[TBL] [Abstract][Full Text] [Related]
13. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta.
Shiou SR; Datta PK; Dhawan P; Law BK; Yingling JM; Dixon DA; Beauchamp RD
J Biol Chem; 2006 Nov; 281(45):33971-81. PubMed ID: 16959768
[TBL] [Abstract][Full Text] [Related]
14. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
Sandberg T; Casslén B; Gustavsson B; Benraad TJ
Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
17. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
Thalacker FW; Nilsen-Hamilton M
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
[TBL] [Abstract][Full Text] [Related]
18. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
Stroschein SL; Wang W; Luo K
J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
